{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T04:00:14Z","timestamp":1781236814650,"version":"3.54.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32100680"],"award-info":[{"award-number":["32100680"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.cca.2024.117889","type":"journal-article","created":{"date-parts":[[2024,3,24]],"date-time":"2024-03-24T23:24:32Z","timestamp":1711322672000},"page":"117889","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Newborn genetic screening for Fabry disease: Insights from a retrospective analysis in Nanjing, China"],"prefix":"10.1016","volume":"557","author":[{"given":"Yun","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian-Wei","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Yun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Yang","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Hong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Ying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2024.117889_b0005","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.ymgme.2018.02.014","article-title":"Fabry disease revisited: Management and treatment recommendations for adult patients","volume":"123","author":"Ortiz","year":"2018","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.cca.2024.117889_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2023.107585","article-title":"An expert consensus on the recommendations for the use of biomarkers in fabry disease","volume":"139","author":"Burlina","year":"2023","journal-title":"Mol Genet Metab."},{"key":"10.1016\/j.cca.2024.117889_b0015","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.tcm.2017.10.001","article-title":"Fabry disease: review and experience during newborn screening","volume":"28","author":"Hsu","year":"2018","journal-title":"Trends Cardiovasc Med."},{"key":"10.1016\/j.cca.2024.117889_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110779","article-title":"Therapeutic advances in fabry disease: the future awaits","volume":"131","author":"Kant","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.cca.2024.117889_b0025","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1681\/ASN.2016090964","article-title":"Characterization of classical and nonclassical fabry disease: a multicenter study","volume":"28","author":"Arends","year":"2017","journal-title":"J Am Soc Nephrol."},{"key":"10.1016\/j.cca.2024.117889_b0030","doi-asserted-by":"crossref","first-page":"2027852","DOI":"10.1080\/19490976.2022.2027852","article-title":"Fabry disease - a multisystemic disease with gastrointestinal manifestations","volume":"14","author":"Lenders","year":"2022","journal-title":"Gut Microbes"},{"key":"10.1016\/j.cca.2024.117889_b0035","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ymgme.2010.03.020","article-title":"Plasma globotriaosylsphingosine as a biomarker of fabry disease","volume":"100","author":"Togawa","year":"2010","journal-title":"Mol Genet Metab."},{"key":"10.1016\/j.cca.2024.117889_b0040","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.ymgme.2014.02.004","article-title":"High-throughput detection of common sequence variations of fabry disease in Taiwan using DNA mass spectrometry","volume":"111","author":"Lee","year":"2014","journal-title":"Mol Genet Metab."},{"key":"10.1016\/j.cca.2024.117889_b0045","article-title":"Prevalence of lysosomal storage disorders in Australia from 2009 to 2020","volume":"19","author":"Chin","year":"2022","journal-title":"Lancet Reg Health West Pac."},{"key":"10.1016\/j.cca.2024.117889_b0050","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ymgme.2022.07.010","article-title":"An expert consensus on practical clinical recommendations and guidance for patients with classic fabry disease","volume":"137","author":"Germain","year":"2022","journal-title":"Mol Genet Metab."},{"key":"10.1016\/j.cca.2024.117889_b0055","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1038\/s41591-020-0966-5","article-title":"The role of exome sequencing in newborn screening for inborn errors of metabolism","volume":"26","author":"Adhikari","year":"2020","journal-title":"Nat Med."},{"key":"10.1016\/j.cca.2024.117889_b0060","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.ajhg.2020.08.001","article-title":"Genomic sequencing for newborn screening: results of the NC NEXUS project","volume":"107","author":"Roman","year":"2020","journal-title":"Am J Hum Genet."},{"key":"10.1016\/j.cca.2024.117889_b0065","doi-asserted-by":"crossref","first-page":"e2331162","DOI":"10.1001\/jamanetworkopen.2023.31162","article-title":"Genomic sequencing as a first-tier screening test and outcomes of newborn screening","volume":"6","author":"Chen","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.cca.2024.117889_b0070","article-title":"Newborn screening with targeted sequencing: a multicenter investigation and a pilot clinical study in China","author":"Hao","year":"2021","journal-title":"Journal of Genetics and Genomics = Yi Chuan Xue Bao."},{"key":"10.1016\/j.cca.2024.117889_b0075","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1186\/s13023-021-02116-5","article-title":"NeoSeq: a new method of genomic sequencing for newborn screening","volume":"16","author":"Wang","year":"2021","journal-title":"Orphanet J Rare Dis."},{"key":"10.1016\/j.cca.2024.117889_b0080","doi-asserted-by":"crossref","DOI":"10.1007\/s12519-022-00670-x","article-title":"A multicenter prospective study of next-generation sequencing-based newborn screening for monogenic genetic diseases in China","author":"Yang","year":"2023","journal-title":"World J Pediatr."},{"key":"10.1016\/j.cca.2024.117889_b0085","first-page":"321","article-title":"Cut-off values of neonatal lysosomal storage disease-related enzymes detected by tandem mass spectrometry","volume":"51","author":"Li","year":"2022","journal-title":"Zhejiang Da Xue Xue Bao Yi Xue Ban"},{"key":"10.1016\/j.cca.2024.117889_b0090","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s10545-017-0098-3","article-title":"Newborn screening for lysosomal storage disorders by tandem mass spectrometry in north East Italy","volume":"41","author":"Burlina","year":"2018","journal-title":"J Inherit Metab Dis."},{"key":"10.1016\/j.cca.2024.117889_b0095","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med."},{"key":"10.1016\/j.cca.2024.117889_b0100","doi-asserted-by":"crossref","DOI":"10.1007\/s12519-022-00522-8","article-title":"Application of next generation sequencing in the screening of monogenic diseases in China, 2021: a consensus among chinese newborn screening experts","author":"Tong","year":"2022","journal-title":"World J Pediatr."},{"key":"10.1016\/j.cca.2024.117889_b0105","first-page":"281","article-title":"Principles and practice of mass screening for disease","volume":"65","author":"Wilson","year":"1968","journal-title":"Boletin De La Oficina Sanitaria Panamericana"},{"key":"10.1016\/j.cca.2024.117889_b0110","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/gim.2014.120","article-title":"Fabry disease in infancy and early childhood: a systematic literature review","volume":"17","author":"Laney","year":"2015","journal-title":"Genet Med."},{"key":"10.1016\/j.cca.2024.117889_b0115","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/GIM.0b013e318211a7e1","article-title":"Lysosomal storage diseases: diagnostic confirmation and management of presymptomatic individuals","volume":"13","author":"Wang","year":"2011","journal-title":"Genet Med."},{"key":"10.1016\/j.cca.2024.117889_b0120","doi-asserted-by":"crossref","DOI":"10.3390\/biom12101460","article-title":"An overview of Molecular mechanisms in fabry disease","volume":"12","author":"Amodio","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.cca.2024.117889_b0125","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1086\/504601","article-title":"High incidence of later-onset fabry disease revealed by newborn screening","volume":"79","author":"Spada","year":"2006","journal-title":"Am J Hum Genet."},{"key":"10.1016\/j.cca.2024.117889_b0130","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jpeds.2014.09.023","article-title":"Lysosomal storage disorder screening implementation: findings from the first six months of full population pilot testing in Missouri","volume":"166","author":"Hopkins","year":"2015","journal-title":"J. Pediatr."},{"key":"10.1016\/j.cca.2024.117889_b0135","article-title":"Newborn screening for fabry disease in the western region of Japan","volume":"22","author":"Sawada","year":"2020","journal-title":"Mol Genet Metab Rep."},{"key":"10.1016\/j.cca.2024.117889_b0140","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1161\/CIRCGENETICS.109.862920","article-title":"High incidence of the cardiac variant of fabry disease revealed by newborn screening in the Taiwan chinese population","volume":"2","author":"Lin","year":"2009","journal-title":"Circ Cardiovasc Genet."},{"key":"10.1016\/j.cca.2024.117889_b0145","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1002\/humu.21074","article-title":"Newborn screening for fabry disease in Taiwan reveals a high incidence of the later-onset GLA mutation c.936+919G>A (IVS4+919G>A)","volume":"30","author":"Hwu","year":"2009","journal-title":"Hum Mutat."},{"key":"10.1016\/j.cca.2024.117889_b0150","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ymgme.2017.06.002","article-title":"Functional and biological studies of \u03b1-galactosidase a variants with uncertain significance from newborn screening in Taiwan","volume":"123","author":"Liao","year":"2018","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.cca.2024.117889_b0155","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/cge.12613","article-title":"X-chromosome inactivation in female patients with fabry disease","volume":"89","author":"Echevarria","year":"2016","journal-title":"Clin Genet."},{"key":"10.1016\/j.cca.2024.117889_b0160","doi-asserted-by":"crossref","first-page":"e2029","DOI":"10.1002\/mgg3.2029","article-title":"X-chromosomal inactivation patterns in women with fabry disease","volume":"10","author":"Wagenhauser","year":"2022","journal-title":"Mol Genet Genomic Med."},{"key":"10.1016\/j.cca.2024.117889_b0165","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/jmedgenet-2014-102872","article-title":"Plasma globotriaosylsphingosine in relation to phenotypes of fabry disease","volume":"52","author":"Smid","year":"2015","journal-title":"J Med Genet."},{"key":"10.1016\/j.cca.2024.117889_b0170","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ymgme.2016.10.006","article-title":"Plasma LysoGb3: a useful biomarker for the diagnosis and treatment of fabry disease heterozygotes","volume":"120","author":"Nowak","year":"2017","journal-title":"Mol Genet Metab."},{"key":"10.1016\/j.cca.2024.117889_b0175","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/s41436-020-00968-z","article-title":"Assessment of plasma lyso-Gb(3) for clinical monitoring of treatment response in migalastat-treated patients with fabry disease","volume":"23","author":"Bichet","year":"2021","journal-title":"Genet Med."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000989812400130X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000989812400130X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T01:26:58Z","timestamp":1737682018000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000989812400130X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":35,"alternative-id":["S000989812400130X"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2024.117889","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Newborn genetic screening for Fabry disease: Insights from a retrospective analysis in Nanjing, China","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2024.117889","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"117889"}}